Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice

This publication has 45 references indexed in Scilit:

• Immune deviation by mucosal antigen administration suppresses gene-transfer–induced inhibitor formation to factor IX
  Blood, 2006
• Sustained Phenotypic Correction of Canine Hemophilia B After Systemic Administration of Helper-Dependent Adenoviral Vector
  Human Gene Therapy, 2005
• Gene therapy for hemophilia: an imperative to succeed
  Journal of Thrombosis and Haemostasis, 2005
• Systemic protein delivery by muscle-gene transfer is limited by a local immune response
  Blood, 2005
• Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs
  Blood, 2003
• Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy
  Human Gene Therapy, 2002
• Lipopolysaccharide Potentiates the Effect of Hepatocyte Growth Factor upon Replication in Lung, Thyroid, Spleen, and Colon in Rats in Vivo
  Molecular Therapy, 2001
• Inhibitor Antibodies to Factor VIII and Factor IX: Management
  Seminars in Thrombosis and Hemostasis, 2000
• Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells
  Science, 1996
• Neonatally tolerant rats actively eliminate donor‐specific lymphocytes despite persistent chimerism
  European Journal of Immunology, 1996